Alpha, beta-unsaturated sulfones for treating proliferative disorders
US6599932B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2002 |
| Grant date | Jul 29, 2003 |
| Priority date | — |
| Expiry date | Nov 21, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/48
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Sulfones of formula I are useful as antiproliferative agents, including, for example, anticancer agents: wherein:Q1 is selected from the group consisting of(a) a phenyl radical according to formula II  whereinR1, R2, R3, R4 and R5 are independently selected from the group consisting of hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, nitro, cyano, carboxyl, hydroxyl, amino, C1-C6 trifluoroalkoxy and trifluoromethyl;(b) an aromatic radical selected from the group consisting of 1-naphthyl, 2-naphthyl and 9-anthryl; and(c) an aromatic radical according to formula III  whereinn1 is 1 or 2,Y1 and Y2 are independently selected from the group consisting of hydrogen, halogen, and nitro, andX1 is selected from the group consisting of oxygen, nitrogen, sulfur and andQ2 is selected from the group consisting of(d) a phenyl radical according to formula II, as defined above;(e) an aromatic radical selected from the group consisting of 1-naphthyl, 2-naphthyl and 9-anthryl;(f) an aromatic radical according to formula IV  whereinn1 is 1 or 2,Y3 and Y4 are independently selected from the group consisting of hydrogen, halogen, and nitro, andX2, X3 and X4 are independently selected from…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.